Farnesoid X Receptor, through the binding wíth Steroidogenic Fuctor I Responsive Element, inhibits uromutase expression in tumor Leydig cells.

dc.contributor.authorMalivindi,Rocco
dc.contributor.authorSisci,Diego
dc.contributor.authorAndò,Sebastiano
dc.date.accessioned2013-10-21T09:43:40Z
dc.date.available2013-10-21T09:43:40Z
dc.date.issued2013-10-21
dc.descriptionDottoruto di Ricerca in: Biochimica CellulAre ed Attività dei Farmaci in Oncologia, XXII Ciclo, a.a.2008-2009 Campo di Ricerca MED/04-PATOLOGIA GENERALE XXII Cicloen_US
dc.description.sponsorshipUniversità della Calabriaen_US
dc.identifier.urihttp://hdl.handle.net/10955/307
dc.language.isoenen_US
dc.relation.ispartofseriesMED/04;
dc.subjectBiochimica Cellulareen_US
dc.subjectTumore a cellule di Leydigen_US
dc.titleFarnesoid X Receptor, through the binding wíth Steroidogenic Fuctor I Responsive Element, inhibits uromutase expression in tumor Leydig cells.en_US
dc.typeThesisen_US

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Tesi Dottorato Dr Rocco Malivindi.pdf
Size:
4.57 MB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: